Amylyx Pharmaceuticals (AMLX) P/E US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| P/E | ? | 0.00 | -12.4 | 20.1 | -0.85 | -7.89 | -9.93 | |
| Changes by years, y/y, % | -262% | -104% | +825% | |||||
Amylyx Pharmaceuticals. P/E
Amylyx Pharmaceuticals. P/E, changes, %
Amylyx Pharmaceuticals (AMLX) P/E US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/E | ? | -1.39 | -3.05 | -8.50 | -7.89 | -10.2 | -9.93 | |
| Changes by years, y/y, % | -49% | +291% | +899% | +819% | +639% | |||
| Changes by quarters, q/q, % | +61% | +120% | +179% | -7% | +30% | |||